SE9702001D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE9702001D0
SE9702001D0 SE9702001A SE9702001A SE9702001D0 SE 9702001 D0 SE9702001 D0 SE 9702001D0 SE 9702001 A SE9702001 A SE 9702001A SE 9702001 A SE9702001 A SE 9702001A SE 9702001 D0 SE9702001 D0 SE 9702001D0
Authority
SE
Sweden
Prior art keywords
novel compounds
pyrimidinediones
thieno
processes
production
Prior art date
Application number
SE9702001A
Other languages
English (en)
Swedish (sv)
Inventor
David Cheshire
Andrew Cooke
Martin Cooper
David Donald
Mark Furber
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Priority to SE9702001A priority Critical patent/SE9702001D0/xx
Publication of SE9702001D0 publication Critical patent/SE9702001D0/xx
Priority to AT98924705T priority patent/ATE226205T1/de
Priority to PT98924705T priority patent/PT991653E/pt
Priority to CZ0420199A priority patent/CZ297536B6/cs
Priority to AU76808/98A priority patent/AU723708B2/en
Priority to IL13276398A priority patent/IL132763A0/xx
Priority to CN98807378A priority patent/CN1122037C/zh
Priority to BR9809481-5A priority patent/BR9809481A/pt
Priority to TR1999/02904T priority patent/TR199902904T2/xx
Priority to ES98924705T priority patent/ES2184270T3/es
Priority to NZ500853A priority patent/NZ500853A/en
Priority to US09/117,426 priority patent/US6180635B1/en
Priority to PL337126A priority patent/PL199567B1/pl
Priority to SK1513-99A priority patent/SK283589B6/sk
Priority to DK98924705T priority patent/DK0991653T3/da
Priority to HU0003355A priority patent/HU226627B1/hu
Priority to UA99127140A priority patent/UA61111C2/uk
Priority to RU99128111/04A priority patent/RU2225410C2/ru
Priority to JP50056599A priority patent/JP2002500666A/ja
Priority to DE69808765T priority patent/DE69808765T2/de
Priority to CA002289509A priority patent/CA2289509C/fr
Priority to KR1019997011086A priority patent/KR100561988B1/ko
Priority to PCT/SE1998/000935 priority patent/WO1998054190A1/fr
Priority to EP98924705A priority patent/EP0991653B1/fr
Priority to IDW991450A priority patent/ID28432A/id
Priority to EEP199900539A priority patent/EE04018B1/xx
Priority to IL132763A priority patent/IL132763A/en
Priority to IS5264A priority patent/IS1983B/is
Priority to NO19995810A priority patent/NO323752B1/no
Priority to US09/693,896 priority patent/US6342502B1/en
Priority to US09/977,944 priority patent/US6469014B1/en
Priority to US10/265,201 priority patent/US6984644B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
  • Valve-Gear Or Valve Arrangements (AREA)
  • Liquid Crystal (AREA)
SE9702001A 1997-05-28 1997-05-28 Novel compounds SE9702001D0 (sv)

Priority Applications (32)

Application Number Priority Date Filing Date Title
SE9702001A SE9702001D0 (sv) 1997-05-28 1997-05-28 Novel compounds
PT98924705T PT991653E (pt) 1997-05-28 1998-05-18 Novos compostos
DK98924705T DK0991653T3 (da) 1997-05-28 1998-05-18 Nye forbindelser
RU99128111/04A RU2225410C2 (ru) 1997-05-28 1998-05-18 ПРОИЗВОДНЫЕ ТИЕНО[2,3-d]ПИРИМИДИН-2,4(1Н,3Н)-ДИОНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СПОСОБ ЕЕ ПОЛУЧЕНИЯ, СПОСОБ ИММУНОСУПРЕССИИ И СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА ОБСТРУКЦИИ ДЫХАТЕЛЬНЫХ ПУТЕЙ
HU0003355A HU226627B1 (en) 1997-05-28 1998-05-18 Thieno[2,3-d]pyrimidinedione derivatives and pharmaceutical compositions containing them, process for their preparation and use thereof
AU76808/98A AU723708B2 (en) 1997-05-28 1998-05-18 Novel compounds
IL13276398A IL132763A0 (en) 1997-05-28 1998-05-18 Novel compounds
CN98807378A CN1122037C (zh) 1997-05-28 1998-05-18 噻吩并[2,3－d]嘧啶二酮类化合物及其制法、用途和含其的药物组合物
BR9809481-5A BR9809481A (pt) 1997-05-28 1998-05-18 Composto, processo para sua preparação, uso do mesmo, composição farmacêutica, e, processos para sua preparação, para efetuar a imunossupressão e para tratar ou reduzir o risco de uma doença obstrutiva reversìvel das vias aéreas em um paciente
TR1999/02904T TR199902904T2 (xx) 1997-05-28 1998-05-18 Yeni bile�imler.
ES98924705T ES2184270T3 (es) 1997-05-28 1998-05-18 Nuevos compuestos.
NZ500853A NZ500853A (en) 1997-05-28 1998-05-18 Immunosuppressive thieno[2,3-d]pyrimidine derivatives
US09/117,426 US6180635B1 (en) 1997-05-28 1998-05-18 Compounds
PL337126A PL199567B1 (pl) 1997-05-28 1998-05-18 Związki tienopiryminodionu, zawierające je kompozycje farmaceutyczne, sposoby wytwarzania tych zwiazków i ich zastosowanie w terapii
SK1513-99A SK283589B6 (sk) 1997-05-28 1998-05-18 Tieno[2,3-d]pyrimidíndióny, spôsoby ich prípravy, farmaceutické kompozície s ich obsahom a ich použitie
AT98924705T ATE226205T1 (de) 1997-05-28 1998-05-18 Verbindungen
CZ0420199A CZ297536B6 (cs) 1997-05-28 1998-05-18 Thienopyrimidindionový derivát, jeho použití a způsoby přípravy, a farmaceutický prostředek s jeho obsahem a způsob jeho výroby
EEP199900539A EE04018B1 (et) 1997-05-28 1998-05-18 Tieno[2,3-d]pürimidiindioonid, nende valmistamisemeetod ja neid sisaldavad ravimkoostised
UA99127140A UA61111C2 (uk) 1997-05-28 1998-05-18 Тієно[2,3-d]піримідинова сполука, спосіб її одержання, фармацевтична композиція, що її містить, і спосіб її одержання, спосіб здійснення імуносупресії і спосіб лікування
JP50056599A JP2002500666A (ja) 1997-05-28 1998-05-18 新規な化合物
DE69808765T DE69808765T2 (de) 1997-05-28 1998-05-18 Verbindungen
CA002289509A CA2289509C (fr) 1997-05-28 1998-05-18 Nouveaux composes
KR1019997011086A KR100561988B1 (ko) 1997-05-28 1998-05-18 신규 화합물
PCT/SE1998/000935 WO1998054190A1 (fr) 1997-05-28 1998-05-18 Nouveaux composes
EP98924705A EP0991653B1 (fr) 1997-05-28 1998-05-18 Nouveaux composes
IDW991450A ID28432A (id) 1997-05-28 1998-05-18 Senyawa-senyawa baru
IL132763A IL132763A (en) 1997-05-28 1999-11-04 Theo [[2,3 – d] pyrimidine - 2, 4 (H1, H3) Diones - transformed at position 6, processes for their preparation, the compositions containing them and their use in healing
IS5264A IS1983B (is) 1997-05-28 1999-11-23 Ný þíeno[2,3-d]pýrimidíndíón, blöndur sem innihalda þau, aðferðir til framleiðslu þeirra og notkun þeirra í lækningalyf
NO19995810A NO323752B1 (no) 1997-05-28 1999-11-26 Nye tieno(2,3-d)pyrimidindioner, fremgangsmate for fremstilling derav, farmasoytisk preparat som inneholder slike, samt anvendelse derav i terapi.
US09/693,896 US6342502B1 (en) 1997-05-28 2000-10-23 Thieno[2,3-d]pyrimidine diones and their use in the treatment of reversible obstructive airways diseases
US09/977,944 US6469014B1 (en) 1997-05-28 2001-10-17 Thieno[2,3-d] pyrimidinediones, their preparation and use in therapy
US10/265,201 US6984644B2 (en) 1997-05-28 2002-10-07 Treatment of skin disorders using thieno[2,3-D]pyrimidinediones

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702001A SE9702001D0 (sv) 1997-05-28 1997-05-28 Novel compounds

Publications (1)

Publication Number Publication Date
SE9702001D0 true SE9702001D0 (sv) 1997-05-28

Family

ID=20407123

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9702001A SE9702001D0 (sv) 1997-05-28 1997-05-28 Novel compounds

Country Status (28)

Country Link
US (2) US6180635B1 (fr)
EP (1) EP0991653B1 (fr)
JP (1) JP2002500666A (fr)
KR (1) KR100561988B1 (fr)
CN (1) CN1122037C (fr)
AT (1) ATE226205T1 (fr)
AU (1) AU723708B2 (fr)
BR (1) BR9809481A (fr)
CA (1) CA2289509C (fr)
CZ (1) CZ297536B6 (fr)
DE (1) DE69808765T2 (fr)
DK (1) DK0991653T3 (fr)
EE (1) EE04018B1 (fr)
ES (1) ES2184270T3 (fr)
HU (1) HU226627B1 (fr)
ID (1) ID28432A (fr)
IL (2) IL132763A0 (fr)
IS (1) IS1983B (fr)
NO (1) NO323752B1 (fr)
NZ (1) NZ500853A (fr)
PL (1) PL199567B1 (fr)
PT (1) PT991653E (fr)
RU (1) RU2225410C2 (fr)
SE (1) SE9702001D0 (fr)
SK (1) SK283589B6 (fr)
TR (1) TR199902904T2 (fr)
UA (1) UA61111C2 (fr)
WO (1) WO1998054190A1 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801399D0 (sv) 1998-04-21 1998-04-21 Astra Pharma Prod Method and apparatus for filling containers
GB9819384D0 (en) 1998-09-04 1998-10-28 Cerebrus Ltd Chemical compounds II
GB9819382D0 (en) 1998-09-04 1998-10-28 Cerebrus Ltd Chemical compounds I
DE60104677T2 (de) * 2000-05-04 2005-07-28 Astrazeneca Ab THIENO[2,3-d]PYRIMIDINDIONE UND IHRE VERWENDUNG ALS PHARMAZEUTISCHE MITTEL
GB2361917A (en) * 2000-05-04 2001-11-07 Astrazeneca Ab Novel thieno[2,3-d]pyrimidinediones
GB2363377B (en) * 2000-06-14 2004-06-09 Astrazeneca Ab Novel thieno[2,3-d]pyrimidinediones and therapeutic uses thereof
WO2002064598A1 (fr) * 2001-02-14 2002-08-22 Warner-Lambert Company Llc Derives de thieno'2,3-d pyrimidinone utilises comme inhibiteurs de metalloproteinases matricielles
GB0117583D0 (en) * 2001-07-19 2001-09-12 Astrazeneca Ab Novel compounds
GB0118479D0 (en) * 2001-07-28 2001-09-19 Astrazeneca Ab Novel compounds
JP2005518391A (ja) * 2001-12-21 2005-06-23 ノボ　ノルディスク　アクティーゼルスカブ Ｇｋ活性化剤としてのアミド誘導体
CA2744893A1 (fr) * 2002-06-27 2004-01-08 Novo Nordisk A/S Derives d'arylcarbonyle servant d'activateurs de glucokinase
US6890923B2 (en) * 2002-12-16 2005-05-10 Astrazeneca Ab Compounds
SE0300120D0 (sv) 2003-01-17 2003-01-17 Astrazeneca Ab Novel compounds
SE0300119D0 (sv) * 2003-01-17 2003-01-17 Astrazeneca Ab Novel compounds
SE0300117D0 (sv) * 2003-01-17 2003-01-17 Astrazeneca Ab Novel Compounds
PL378221A1 (pl) * 2003-01-17 2006-03-20 Astrazeneca Ab Tienopirydazynony i ich zastosowanie w modulacji choroby autoimmunologicznej
BRPI0506662B8 (pt) * 2004-01-06 2021-05-25 Novo Nordisk As compostos ativadores de glucoquinase
ES2382815T3 (es) * 2005-07-08 2012-06-13 Novo Nordisk A/S Dicicloalquilcarbamoil ureas como activadores de glucoquinasa
KR20080024211A (ko) * 2005-07-08 2008-03-17 노보 노르디스크 에이/에스 디시클로알킬 우레아 글루코키나제 활성제
MX2008000255A (es) 2005-07-14 2008-04-02 Novo Nordisk As Activadores de urea glucocinasa.
JP2009528389A (ja) * 2006-03-02 2009-08-06 シーブイ・セラピューティクス・インコーポレイテッド Ａ２ａアデノシン受容体拮抗剤
CN101186612B (zh) * 2006-11-15 2012-10-03 天津和美生物技术有限公司 可抑制细胞释放肿瘤坏死因子的吡咯啉衍生物及其制备和应用
US7776868B2 (en) * 2006-12-01 2010-08-17 Gilead Palo Alto, Inc. Substituted bicyclic and tricyclic thieno[2,3-d]pyrimidines as A2A adenosine receptor antagonists
JP2010515701A (ja) * 2007-01-09 2010-05-13 ノボ・ノルデイスク・エー／エス ウレアグルコキナーゼアクチベーター
US8318778B2 (en) * 2007-01-11 2012-11-27 Novo Nordisk A/S Urea glucokinase activators
EP2008656A1 (fr) 2007-06-28 2008-12-31 Bergen Teknologioverforing AS Compositions pour le traitement d'hyperphénylalaninémie
SG184767A1 (en) * 2009-03-23 2012-10-30 Glenmark Pharmaceuticals Sa Furopyrimidinedione derivatives as trpa1 modulators
UA123760C2 (uk) * 2011-11-11 2021-06-02 Гіліад Аполло, Ллс Сполука (варіанти) та композиція, що містить сполуку
WO2014042176A1 (fr) * 2012-09-14 2014-03-20 キッセイ薬品工業株式会社 Procédé de production d'un dérivé hétérocyclique fusionné, et production intermédiaire
MX2016004250A (es) * 2013-10-07 2016-07-12 Bayer Pharma AG Tienouracilcarboxamidas ciclicas y usos de las mismas.
UY36586A (es) 2015-03-26 2016-10-31 Bayer Pharma AG Heterociclilmetiltienouracilos y uso de los mismos
AR106472A1 (es) 2015-10-26 2018-01-17 Gilead Apollo Llc Inhibidores de acc y usos de los mismos
KR20180086191A (ko) 2015-11-25 2018-07-30 길리어드 아폴로, 엘엘씨 2,4-디옥소-1,4-디히드로티에노[2,3-d]피리미딘 유도체를 함유하는 살진균 조성물
BR112018010113B1 (pt) 2015-11-25 2022-06-14 Gilead Apollo, Llc Composto de pirazol útil como inibidor da acetil-coa carboxilase (acc)
CN108290902B (zh) 2015-11-25 2021-08-31 吉利德阿波罗公司 酯类acc抑制剂及其用途
BR112018010453B1 (pt) 2015-11-25 2022-06-14 Gilead Apollo, Llc Compostos triazólicos inibindores de acetil coa carboxilase (acc)
EP3423456B1 (fr) 2016-03-02 2023-12-27 Gilead Apollo, LLC Formes solides d'un inhibiteur de thiénopyrimidinedione acc et leurs procédés de production
WO2018041771A1 (fr) 2016-09-02 2018-03-08 Bayer Pharma Aktiengesellschaft Thiéno-uraciles substitués par un groupe (1-méthylcyclopropyl)méthyle et leur utilisation
JP2019529452A (ja) 2016-09-23 2019-10-17 バイエル・アクチエンゲゼルシヤフト Ｎ３−環状置換チエノウラシルおよびその使用
PT3600309T (pt) 2017-03-28 2022-10-03 Gilead Sciences Inc Combinações terapêuticas para o tratamento de doenças hepáticas
KR20210020866A (ko) 2018-06-12 2021-02-24 브이티브이 테라퓨틱스 엘엘씨 인슐린 또는 인슐린 유사체와 조합된 글루코키나제 활성제의 치료적 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU599515B2 (en) * 1987-09-16 1990-07-19 Taiho Pharmaceutical Co., Ltd. Thienopyrimidine derivatives
TW276256B (fr) * 1993-08-26 1996-05-21 Takeda Pharm Industry Co Ltd
FR2750862B1 (fr) * 1996-07-12 1998-10-16 Dupin Jean Pierre Utilisation d'heterocycles diazotes fusionnes avec un systeme aromatique ou heteroaromatique pour le traitement des maladies thrombo-emboliques

Also Published As

Publication number Publication date
AU7680898A (en) 1998-12-30
PL199567B1 (pl) 2008-10-31
WO1998054190A1 (fr) 1998-12-03
IL132763A (en) 2007-03-08
NZ500853A (en) 2001-05-25
HU226627B1 (en) 2009-05-28
KR20010013107A (ko) 2001-02-26
UA61111C2 (uk) 2003-11-17
HUP0003355A2 (hu) 2001-02-28
CN1264382A (zh) 2000-08-23
DK0991653T3 (da) 2003-01-06
TR199902904T2 (xx) 2000-06-21
DE69808765D1 (de) 2002-11-21
HUP0003355A3 (en) 2003-03-28
CA2289509C (fr) 2007-10-02
ATE226205T1 (de) 2002-11-15
PL337126A1 (en) 2000-07-31
CN1122037C (zh) 2003-09-24
EE9900539A (et) 2000-06-15
BR9809481A (pt) 2000-06-20
IS1983B (is) 2005-01-14
CZ420199A3 (cs) 2000-07-12
AU723708B2 (en) 2000-09-07
US6180635B1 (en) 2001-01-30
EP0991653B1 (fr) 2002-10-16
SK283589B6 (sk) 2003-10-07
NO995810D0 (no) 1999-11-26
NO995810L (no) 2000-01-27
ES2184270T3 (es) 2003-04-01
EE04018B1 (et) 2003-04-15
EP0991653A1 (fr) 2000-04-12
US6342502B1 (en) 2002-01-29
SK151399A3 (en) 2000-05-16
JP2002500666A (ja) 2002-01-08
IL132763A0 (en) 2001-03-19
RU2225410C2 (ru) 2004-03-10
ID28432A (id) 2001-05-24
NO323752B1 (no) 2007-07-02
KR100561988B1 (ko) 2006-03-17
CA2289509A1 (fr) 1998-12-03
IS5264A (is) 1999-11-23
DE69808765T2 (de) 2003-07-24
PT991653E (pt) 2003-02-28
CZ297536B6 (cs) 2007-01-03

Similar Documents

Publication Publication Date Title
SE9702001D0 (sv) Novel compounds
EE200000318A (et) Uudsed ühendid
BG103417A (en) Condensed pyrimidine bicyclic derivatives
SE9701398D0 (sv) Novel compounds
DE69804743D1 (de) Pyrazolo[4,3-d]pyrimidin-Derivate und diese enthaltende pharmazeutische Zubereitungen
IL114003A (en) 1,4,6-Trisubstituted 1H-pyrrolo[2,3-b]pyridine and 1-H-pyrazolo[3,4-b] pyridine derivatives and pharmaceutical compositions containing them and some intermediates for their preparation
DE69905170D1 (en) Thiazolopyrimidinderivate
IS5082A (is) Pýrróló[3,4-D]pýrimídínon-afleiður og notkun þeirra sem lyfja
IT1265101B1 (it) Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
SE9802937D0 (sv) Novel compounds
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
AU2001252825A1 (en) Thieno(2,3-d)pyrimidinediones and their use as pharmaceuticals
TR199801251T2 (xx) Eritrosit olu�umunu te�vik i�in thieno (2,3-b) pyrazolo (3,4-D) pyridin-3-on'lar.
IL160160A0 (en) SUBSTITUTED 5,6,6a, 11b-TETRAHYDRO-7-OXA-5-AZA-BENZO[c]FLUORENE-6-CARBOXYLIC ACID DERIVATIVES SERVING AS NMDA ANTAGONISTS
EP0412941A3 (en) Phospholipids for the treatment of multiple sclerosis
MY113450A (en) Anellated b-carbolines
AP9600780A0 (en) Process for the preparation of peroxetine hydrochloride anhydrate and its use as therapeutic agent.